Found "HTA": 339 results
Sort by
Last updated

Mission Report: The 4th Regional Workshop on Advanced Health Economic Evaluation

Executive Summary The 4th Regional Workshop on Advanced Economic Evaluation was held on 23–25 February 2026 at Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) in Puducherry, India. The workshop was co-organized by JIPMER, the Saw Swee Hock School of Public Health, N

Wanrudee Isaranuwatchai, PhD

Dr. Wanrudee Isaranuwatchai is a Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. She is also an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada.H

Developing an Evidence Guide to Strengthen Public Investment Decisions for Digital Health Technologies in Low- and Middle-Income Countries

Digital health technologies (e.g., wearables, electronic health records, and artificial intelligence tools) are increasingly recognized for their potential to enhance care quality, efficiency, and reach of healthcare services while potentially reducing costs [1]. Landscape reviews have shown increasing investments by governments and other stakehold

Using Health Technology Assessment to address inefficient and unequal use of Nilotinib across Indonesia

It is vital to have evidence-informed clinical practice guidelines or clinical indications to guide the usage of high-cost drugs in the benefits package under the Indonesian universal health coverage (JKN), managed by BPJS Kesehatan. A transparent and legit mechanism is required to support and mo

Chayapat Rachatan

Chayapat Rachatan is currently a Project Associate at HITAP. She supports the HTA and health system research. Her research studies focus on COVID-19 policy research and decision support, effectiveness evaluation of COVID-19 vaccine chatbot, cost analysis of governance system in health sector, situational analysis of infectious disease modelling in

Methods for Evaluation of Surrogate Endpoints for HTA Decision Making

Abstract Surrogate endpoints are frequently used as primary outcomes in clinical trials. This is appropriate when they are validated for their ability to predict clinical benefit measured on patient-relevant target outcome(s). Such validation is often lacking, thus increasing uncertainty in the dec

Ryan Jonathan Sitanggang

Ryan Jonathan Sitanggang is an International Cooperation Officer (ICO) at the International Unit of the HITAP Foundation. He works on strengthening HTA networks and systems across Asia through initiatives such as the Asia HTA Registry, the HTAsiaLink Strategic Plan, and regional capacity-building. His role includes managing partnerships, coordinati

Navigating the Landscape of Digital Health: South Korea

Executive Summary Digital health in Korea encompasses a wide range of technologies and services yet lacks a clear legal definition. The Korea Institute for Industrial Economics & Trade (KIET) classifies digital health into hardware, software, and service categories, reflecting the diverse lan
10 / Page